Qualisure Diagnostics Inc. and OncoHelix Inc. will collaborate to prepare Thyroid GuidePx™ for introduction to the clinic. OncoHelix’s expertise in next generation sequencing (NGS) and Precision Oncology will be leveraged to perform the validation necessary to make this test available in Canada.
Sign up to receive updates from Qualisure regarding our latest developments in precision medicine tools.
